180 related articles for article (PubMed ID: 3628022)
1. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
Arning G; Ehrenheim C; Schober O; Hundeshagen H
Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
[TBL] [Abstract][Full Text] [Related]
2. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
[TBL] [Abstract][Full Text] [Related]
3. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
[TBL] [Abstract][Full Text] [Related]
4. Metastatic papillary thyroid carcinoma with normal serum thyroglobulin level.
Miller JH; Marcus CS
Clin Nucl Med; 1988 Sep; 13(9):652-3. PubMed ID: 3180613
[TBL] [Abstract][Full Text] [Related]
5. The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma.
Dadparvar S; Krishna L; Brady LW; Slizofski WJ; Brown SJ; Chevres A; Micaily B
Cancer; 1993 Jun; 71(11):3767-73. PubMed ID: 8490927
[TBL] [Abstract][Full Text] [Related]
6. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
[TBL] [Abstract][Full Text] [Related]
7. Sustained and diffuse 131I avid bone metastases with low thyroglobulin levels in a patient with papillary thyroid carcinoma.
Zhao CL; Qiu ZL; Chen LB; Yuan ZB; Luo QY
Clin Nucl Med; 2013 May; 38(5):375-7. PubMed ID: 23567283
[TBL] [Abstract][Full Text] [Related]
8. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE
Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
[TBL] [Abstract][Full Text] [Related]
9. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
10. [Follow-up of patients with differentiated thyroid cancer: determination of serum thyroglobulin in place of routine 131I scintigraphy?].
Schatz H; Grebe SF; Horn W; Müller H
Wien Klin Wochenschr; 1984 May; 96(10):389-93. PubMed ID: 6475061
[TBL] [Abstract][Full Text] [Related]
11. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
Ramanna L; Waxman A; Braunstein G
J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
[TBL] [Abstract][Full Text] [Related]
12. Interlesional 'flip-flop' between
Basu S; Kalshetty A; Fargose P
Natl Med J India; 2017; 30(1):48. PubMed ID: 28731009
[No Abstract] [Full Text] [Related]
13. Value of post-therapeutic ¹³¹I scintigraphy in stimulated serum thyroglobulin-negative patients with metastatic differentiated thyroid carcinoma.
Shen CT; Wei WJ; Qiu ZL; Song HJ; Luo QY
Endocrine; 2016 Feb; 51(2):283-90. PubMed ID: 26093847
[TBL] [Abstract][Full Text] [Related]
14. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
[TBL] [Abstract][Full Text] [Related]
15. [Value of serum thyroglobulin assays in cancers of the thyroid].
Schlumberger M; Fragu P; Travagli JP; Gardet P; Lumbroso J; Charbord P; Lacour J; Parmentier C
Nouv Presse Med; 1982 Oct; 11(42):3101-5. PubMed ID: 7177824
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 99Tcm-tetrofosmin with 201Tl and 131I in the detection of differentiated thyroid cancer metastases.
Nishiyama Y; Yamamoto Y; Ono Y; Takahashi K; Nakano S; Satoh K; Ohkawa M; Tanabe M
Nucl Med Commun; 2000 Oct; 21(10):917-23. PubMed ID: 11130332
[TBL] [Abstract][Full Text] [Related]
17. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
[TBL] [Abstract][Full Text] [Related]
18. [Significance of thyroglobulin as a tumor marker in the serum of patients with differentiated thyroid carcinoma: longitudinal and cross-sectional studies (author's transl)].
Schatz H; Grebe S; Mäser E; Teuber J; Horn W; Schröder O; Schatz C
Klin Wochenschr; 1982 May; 60(9):457-64. PubMed ID: 7045510
[TBL] [Abstract][Full Text] [Related]
19. [Chest X ray: routine indication in the follow-up of differentiated thyroid cancer?].
Lorenzen J; Beese M; Mester J; Brumma K; Beyer W; Clausen M
Nuklearmedizin; 1998; 37(6):208-12. PubMed ID: 9770715
[TBL] [Abstract][Full Text] [Related]
20. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
Rudavsky AZ; Freeman LM
J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
